Globalt Investments LLC / Ga Vertex Pharmaceuticals Inc Transaction History
Globalt Investments LLC / Ga
- $2.61 Trillion
- Q4 2024
A detailed history of Globalt Investments LLC / Ga transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Globalt Investments LLC / Ga holds 7,988 shares of VRTX stock, worth $3.7 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
7,988
Previous 7,925
0.79%
Holding current value
$3.7 Million
Previous $3.69 Billion
12.72%
% of portfolio
0.12%
Previous 0.14%
Shares
5 transactions
Others Institutions Holding VRTX
# of Institutions
1,728Shares Held
223MCall Options Held
1.65MPut Options Held
1.38M-
Capital World Investors Los Angeles, CA28.3MShares$13.1 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$10.8 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.86 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.47 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$4.82 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $119B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...